These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1946308)

  • 1. Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse.
    Lundquist I; Panagiotidis G; Stenström A
    Pancreas; 1991 Sep; 6(5):522-7. PubMed ID: 1946308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-dopa-induced dopamine accumulation on 45Ca2+ efflux and insulin secretion in isolated rat islets.
    Ahrén B; Lundquist I
    Pharmacology; 1985; 30(2):71-82. PubMed ID: 3883370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of beta 2-adrenoceptor stimulation and glucose on islet monoamine oxidase activity and insulin secretory response in the mouse.
    Panagiotidis G; Stenström A; Lundquist I
    Pancreas; 1993 May; 8(3):368-74. PubMed ID: 8387193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
    Feldman JM; Chapman B
    Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion.
    Ericson LE; Håkanson R; Lundquist I
    Diabetologia; 1977 Apr; 13(2):117-24. PubMed ID: 404204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose modulation of islet monoamine oxidase activity in lean and obese hyperglycemic mice.
    Panagiotidis G; Lindström P; Stenström A; Lundquist I
    Metabolism; 1993 Nov; 42(11):1398-404. PubMed ID: 8231833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pancreatic islet monoamine oxidase by adrenergic antagonists and ethanol.
    Feldman JM
    Endocr Res Commun; 1975; 2(8):503-20. PubMed ID: 4295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of benserazide on changes in monoamine oxidase activity in some rat tissues following treatment with L-DOPA.
    Callingham BA; Lyles GA
    J Auton Pharmacol; 1980 Nov; 1(1):9-16. PubMed ID: 7341636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of mouse islet function by 5-hydroxytryptamine, dopamine and their precursors.
    Lindstöm P
    Acta Biol Med Ger; 1982; 41(12):1185-90. PubMed ID: 6765161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse.
    Panagiotidis G; Stenström A; Lundquist I
    Eur J Pharmacol; 1993 Mar; 233(2-3):285-90. PubMed ID: 8096820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase (MAO) in pancreatic islets of the mouse: some characteristics and the effect of chemical sympathectomy.
    Stenström A; Panagiotidis G; Lundquist I
    Diabetes Res; 1989 Jun; 11(2):81-4. PubMed ID: 2515934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual action of antidepressant drugs (MAO inhibitors) on insulin release.
    Aleyassine H; Gardiner RJ
    Endocrinology; 1975 Mar; 96(3):702-10. PubMed ID: 1090438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster.
    Zern RT; Bird JL; Feldman JM
    Diabetologia; 1980 Apr; 18(4):341-6. PubMed ID: 6998806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pancreatic islet monoamine oxidase.
    Feldman JM; Chapman B
    Metabolism; 1975 May; 24(5):581-8. PubMed ID: 1092954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic muscarinic effects on insulin release in mice.
    Lundquist I
    Pharmacology; 1982; 25(6):338-47. PubMed ID: 6818565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of substrates for aromatic L-amino acid decarboxylase on insulin secretion.
    Lindström P; Sehlin J
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):21-6. PubMed ID: 3310492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.